...
首页> 外文期刊>Clinical practice. >Diagnosis and treatment of myelofibrosis: A personal perspective
【24h】

Diagnosis and treatment of myelofibrosis: A personal perspective

机译:骨髓纤维化的诊断和治疗:个人观点

获取原文
获取原文并翻译 | 示例
           

摘要

Myelofibrosis can arise de novo or following one of the other Philadelphia-negative myeloproliferative neoplasms. The differential diagnosis may be challenging and can include other entities which may also express the JAK2 V617F mutation, such as chronic myelomonocytic leukemia and/or refractory anemia with ring sideroblasts. Traditionally a difficult disease to treat with only a small proportion of patients eligible for a curative bone marrow transplant, this field has recently changed radically with the introduction of JAK inihibitors, the first in class being ruxolitinib.
机译:骨髓纤维化可从头发生或继费城阴性的其他骨髓增生性肿瘤之一后出现。鉴别诊断可能具有挑战性,并且可能包括可能也表达JAK2 V617F突变的其他实体,例如慢性粒细胞单核细胞白血病和/或伴有环状成铁细胞的难治性贫血。传统上,这是一种很难治疗的疾病,只有一小部分适合治愈性骨髓移植的患者可以治疗。最近,随着JAK抑制剂的引入,这一领域发生了根本性的改变,其中首例是鲁索替尼。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号